Conception rate after gonadotropin therapy in hyperprolactinemia and normoprolactinemia.
The cumulative pregnancy rate after gonadotropin treatment was evaluated in 63 hyperprolactinemic and 242 normoprolactinemic women. All pregnancies in the hyperprolactinemic patients were achieved within four treatment cycles; the cumulative pregnancy was 62% as compared with 29% in normoprolactinemics. The same results were obtained when patients were divided according to endogenous estrogenic activity. These results imply that in bromocriptine failures there is no need to lower prolactin levels to achieve pregnancy with gonadotropins.
D000568:Amenorrhea / Q000097:blood / Q000188:drug therapy*; D006063:Chorionic Gonadotropin / Q000627:therapeutic use*; D004967:Estrogens / Q000652:urine; D005260:Female; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use; D010060:Ovulation; D011247:Pregnancy; D011388:Prolactin / Q000097:blood*
D006063:Chorionic Gonadotropin; D004967:Estrogens; D008596:Menotropins; D011388:Prolactin